Skip to content

13F-HR filed by NEXTBio Capital Management LP

NEXTBio Capital Management LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-13 13:51:27 UTC, with 25 holding rows worth $234,373,442.

Accession
0001172661-26-004969
Filed
2026-11-13
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 25 entries on the cover page, a total value of $234,373,442 stated on the cover page (in dollars after the unit check, H1), rows summing to $234,373,442 with VALUE read as dollars as filed, 13F file number 028-26345. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PROTAGONIST THERAPEUTICS74366E102COM219,333$30,901,826dollars as filed
SHATTUCK LABS INC82024L103COMMON STOCK3,727,348$25,420,513dollars as filed
COMPASS PATHWAYS PLC20451W101SPONSORED ADS1,775,759$22,090,442dollars as filed
RHYTHM PHARMACEUTICALS INC76243J105COM131,758$12,545,338dollars as filed
VOR BIOPHARMA INC929033207COMMON STOCK620,931$11,847,363dollars as filed
PHARVARIS NVN69605108COMMON STOCK372,552$11,817,349dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock310,225$11,537,268dollars as filed
ZENAS BIOPHARMA INC COM98937L105Stock426,736$11,509,070dollars as filed
PALVELLA THERAPEUTICS INC697947109COMMON STOCK80,409$11,090,813dollars as filed
STRUCTURE THERAPEUTICS INC COMP86366E106EQUITY312,496$9,771,750dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM684,476$9,219,892dollars as filed
ENTERA BIO LTDM40527109SHS2,923,937$8,508,657dollars as filed
VERASTEM INC92337C203COMMON STOCK906,742$7,299,273dollars as filed
INVENTIVA SA46124U107ADS1,787,984$6,597,661dollars as filed
ZAI LAB LTD ADR98887Q104ADR238,362$6,278,455dollars as filed
VAXCYTE INC COM92243G108Stock107,223$6,100,989dollars as filed
COGENT BIOSCIENCES INC19240Q201COM178,036$5,700,713dollars as filed
KORSANA BIOSCIENCES INC23255M303COMMON STOCK175,403$5,612,896dollars as filed
CRESCENT BIOPHARMA INCG2545C104COMMON STOCK372,856$5,439,969dollars as filed
BLOSSOMHILL THERAPEUTICS INC095130100COM250,000$4,660,000dollars as filed
DISC MEDICINE INC COM254604101Stock52,655$3,446,796dollars as filed
LB PHARMACEUTICALS INC50180M108COMMON STOCK69,549$2,669,291dollars as filed
ADARx Pharmaceuticals, Inc.00654F105Common Stock, par value $0.0001 per share100,000$1,994,000dollars as filed
MONTE ROSA THERAPEUTICS INC61225M102COM111,455$1,329,658dollars as filed
EVOMMUNE INC30054Y107COMMON STOCK119,063$983,460dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-26-004969this filing2026-11-13